BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

426 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 161 increasing their positions, 149 reducing their positions, and 36 closing their positions.

Holders
426
Holders Change
+8
Holders Change %
+1.91%
% of All Funds
10.64%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.35%
New
46
Increased
161
Reduced
149
Closed
36
Calls
$84.4M
Puts
$97.6M
Net Calls
-$13.1M
Net Calls Change
-$19.7M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$1.2B
2
BBA
2
Baker Bros. Advisors
New York
$536M
3
Millennium Management
3
Millennium Management
New York
$80.4M
4
TCIM
4
TIAA CREF Investment Management
New York
$204M
5
UIM
5
USS Investment Management
United Kingdom
$99M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$13.9M
2
SIG
2
Senator Investment Group
New York
$0
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$1.72B
4
Ameriprise
4
Ameriprise
Minnesota
$84.9M
5
Viking Global Investors
5
Viking Global Investors
Connecticut
$23.6M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.72B 18,898,699 -744,734 -4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.3B 14,345,027 +642,623 +5%
Jennison Associates
3
Jennison Associates
New York
$1.2B 13,242,773 +3,348,168 +34%
BlackRock
4
BlackRock
New York
$1.04B 11,400,960 +335,508 +3%
Primecap Management
5
Primecap Management
California
$846M 9,310,224 +597,956 +7%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$844M 9,295,522 -407,488 -4%
Sands Capital Management
7
Sands Capital Management
Virginia
$772M 8,505,481 -466,924 -5%
BBA
8
Baker Bros. Advisors
New York
$536M 5,905,673 +1,099,190 +23%
Invesco
9
Invesco
Georgia
$382M 4,203,916 +570,718 +16%
State Street
10
State Street
Massachusetts
$354M 3,896,250 -105,279 -3%
Temasek Holdings
11
Temasek Holdings
Singapore
$315M 3,472,712 – –
PAI
12
Palo Alto Investors
California
$217M 2,384,719 +2,100 +0.1%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$215M 2,362,518 +82,813 +4%
TCIM
14
TIAA CREF Investment Management
New York
$204M 2,251,011 +875,686 +64%
MNA
15
Manning & Napier Advisors
New York
$192M 2,118,486 +426,016 +25%
Bank of America
16
Bank of America
North Carolina
$187M 2,058,447 +198,573 +11%
Goldman Sachs
17
Goldman Sachs
New York
$178M 1,964,069 +424,610 +28%
Franklin Resources
18
Franklin Resources
California
$155M 1,711,021 +88,964 +5%
JPMorgan Chase & Co
19
JPMorgan Chase & Co
New York
$151M 1,660,119 -547,061 -25%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$149M 1,640,565 +153,834 +10%
O
21
OppenheimerFunds
New York
$144M 1,587,950 -81,407 -5%
Wells Fargo
22
Wells Fargo
California
$141M 1,552,042 -350,675 -18%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$127M 1,402,840 +79,799 +6%
Deutsche Bank
24
Deutsche Bank
Germany
$124M 1,368,940 +39,727 +3%
ClearBridge Investments
25
ClearBridge Investments
New York
$123M 1,355,822 +22,864 +2%
1
2 3 4 5